(adding composition & link for Mixtard) |
No edit summary |
||
(20 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Insulin| |
{{Insulin| |
||
− | bgcolor=# |
+ | bgcolor=#CCC| |
− | fgcolor=# |
+ | fgcolor=#0000| |
name=Mixtard 20| |
name=Mixtard 20| |
||
generic=[[Mixed Insulins|R/Neutral/NPH/Isophane Mix]]| |
generic=[[Mixed Insulins|R/Neutral/NPH/Isophane Mix]]| |
||
Line 10: | Line 10: | ||
suspension=[[isophane]]| |
suspension=[[isophane]]| |
||
line=[[Novo Nordisk|Novo]]| |
line=[[Novo Nordisk|Novo]]| |
||
+ | aliases=[[Actraphane 20/80]], [[Penmix 20]]<ref>[http://www.medsafe.govt.nz/Profs/DataSheet/PenmixMixtardProtaphaneinj.htm Medsafe NZ Penmix 20]</ref>| |
||
− | aliases=[[Actraphane 20/80]]| |
||
− | similar= |
+ | similar=[[Humulin M2]]| |
cataction= |
cataction= |
||
*onset Xh, |
*onset Xh, |
||
Line 33: | Line 33: | ||
}} |
}} |
||
− | A mixed, intermediate-acting insulin made by [[Novo Nordisk]] |
+ | A mixed, intermediate-acting insulin<ref>[http://emc.medicines.org.uk/medicine/15974/XPIL/Mixtard+30+100+IU+ml++Suspension+for+Injection+in+a+vial/ Electronic Medicines Compendium (EMC) UK-Patient Information-Mixtard 20]</ref><ref>[http://www.drgc.cwc.net/Care_pathway/Patient_information/Insulin/Novo_insulins.htm Prescribing Novo Insulins]</ref> made by [[Novo Nordisk]] containing 20% R/neutral insulin and 80% NPH/isophane insulin crystals<ref>[http://www.emea.europa.eu/humandocs/PDFs/EPAR/mixtard/226802en6.pdf EMEA Scientific Discussion-Mixtard]</ref><ref>[http://www.remedyfind.com/treatments/0/1299/Insulin:%20Humulin%2020/80%20etc.%20(R%20Human;%20NPH%20Insulin) Humulin 20/80-NPH;R Human Insulin Remedyfind.com]</ref>. |
+ | Comparable product is also made by Novo: [[Actraphane 20/80]]<ref>[http://www.emea.europa.eu/humandocs/PDFs/EPAR/actraphane/504002en6.pdf EMEA Scientific Discussion-Actraphane]</ref>. |
||
⚫ | |||
+ | |||
+ | Eli Lilly once produced a similar insulin in the EU & UK called [[Humulin M2]]<ref>[http://www.yorkshirediabetes.com/downloads/1071_LLY_Diabetes_RangeChar.pdf Lilly Product Sheet & Time Activity Profiles]</ref>; it was discontinued in July 2004<ref>[http://www.pharmj.com/editorial/20040327/products/p379products.html Withdrawal of Humulin M2 July 2004]</ref>. |
||
+ | |||
+ | Mixtard 20 was discontinued December 31, 2007.<ref>[http://www.ukmicentral.nhs.uk/therapeu/pace/PACE0604.pdf Insulin Discontinuations-UK]</ref><ref>[http://www.yorkshirediabetes.com/downloads/A4Humandis.pdf Chart of Discontinued Novo Human Insulins]</ref> |
||
+ | |||
+ | ==References== |
||
+ | <references/> |
||
+ | |||
⚫ |
Latest revision as of 21:56, 25 June 2009
Mixtard 20 | |
R/Neutral/NPH/Isophane Mix by Novo Nordisk | |
intermediate-acting | r-DNA/GE/GM |
U100 | isophane |
Line | Novo |
Also known as | Actraphane 20/80, Penmix 20[1] |
Similar to | Humulin M2 |
Action in cats |
|
Action in dogs |
|
Use and Handling | |
---|---|
Type | cloudy |
Shelf Life | 30 months |
When opened | 6 weeks room temp. |
In pen | 6 weeks room temp. |
Notes |
|
A mixed, intermediate-acting insulin[2][3] made by Novo Nordisk containing 20% R/neutral insulin and 80% NPH/isophane insulin crystals[4][5].
Comparable product is also made by Novo: Actraphane 20/80[6].
Eli Lilly once produced a similar insulin in the EU & UK called Humulin M2[7]; it was discontinued in July 2004[8].
Mixtard 20 was discontinued December 31, 2007.[9][10]
References
- ↑ Medsafe NZ Penmix 20
- ↑ Electronic Medicines Compendium (EMC) UK-Patient Information-Mixtard 20
- ↑ Prescribing Novo Insulins
- ↑ EMEA Scientific Discussion-Mixtard
- ↑ Humulin 20/80-NPH;R Human Insulin Remedyfind.com
- ↑ EMEA Scientific Discussion-Actraphane
- ↑ Lilly Product Sheet & Time Activity Profiles
- ↑ Withdrawal of Humulin M2 July 2004
- ↑ Insulin Discontinuations-UK
- ↑ Chart of Discontinued Novo Human Insulins